Will I need to take these injections indefinitely
1.4.2 Evidence gap: metabolic proxies as insufficient substitutes for reproductive outcomes Despite the proliferation of guidelines and reviews regarding GLP-1RAs, the majority remain focused on metabolic syndrome, weight management, and cardiorenal protection
In the pivotal SURPASS clinical trials evaluating tirzepatide for type 2 diabetes, and the SURMOUNT trials for weight management, sweating or hyperhidrosis was not reported among the adverse events occurring with notable frequency
Every patient starts with Heather a full medical history, current labs, and an honest conversation about goals, lifestyle, and what GLP-1 therapy can and cannot do
Administration of AC not only reduced tumor burden, but also ameliorated chemotherapy-induced muscle fatigue-like behavior
any off-label oral use is a specialist decision and should only occur under medical supervision